In 1975 a Kodak engineer named Steven Sasson assembled a prototype that captured an image electronically and recorded it onto cassette tape. It was the first digital camera. Kodak owned the invention outright, went on to patent widely across digital imaging, and earned substantial licensing revenue from those patents for years afterwards.
In January 2012, Kodak filed for Chapter 11 bankruptcy protection. Later that year it sold a portfolio of around 1,100 digital imaging patents to a consortium of technology companies for approximately $525 million.
The IP move
The patents were not the failure. By the end they were among the few assets substantial enough to matter to creditors at all. The failure was strategic, and it was a failure of will rather than of foresight. The company that held rights over the technology destined to destroy its film business was structurally incapable of letting that happen on purpose. Film was enormously profitable, the sales organisation was built around it, and every internal incentive pointed at protecting the present.
What the portfolio did do is worth noting, because it is the part that gets lost in the retelling. It produced real licensing income across many years. It gave the company leverage in negotiations it would otherwise have entered empty-handed. It bought time. And at the end it converted into roughly half a billion dollars for creditors. A well-constructed portfolio kept paying long after the operating business had stopped working.
It simply could not substitute for a decision the business declined to make. Patents describe where a company could go. They do not move it there.
The takeaways
Owning an invention and commercialising it are separate problems, and companies routinely solve only the first one.
A portfolio holds value independent of the business that created it, realisable through licensing, sale or security.
Patents covering a technology you have decided not to pursue mostly slow a competitor down. They do not build your future for you.
Portfolio strategy is a question about where the business is going, not an administrative question about what to file next.
A portfolio that points somewhere management refuses to go is itself a piece of information worth acting on.
The lesson for your business
Review the portfolio against the strategy rather than against the filing calendar. For every significant right, answer three questions: what is it protecting, what is it earning, and would we file it again today knowing what we now know. Rights that fail all three should be licensed out, sold, or deliberately allowed to lapse so that the renewal budget goes somewhere useful. Rights that point at a market the business keeps declining to enter are not a portfolio problem at all. They are a warning about the business.
